Avid Bioservices Inc (CDMO)

[bfiest]

As a follow up:

“The Guidelines acknowledge that combination products can satisfy the inventive step standard, at least when a synergistic effect can be demonstrated. In fact, there are good policy rationales supporting the availability of patent protection for inventive combination products, particularly, but not exclusively, when the combination results in a synergistic effect. Patents provide an incentive for innovators to discover combination products that provide improved therapeutic outcome compared to either individual active ingredient. Perhaps even more significantly, patents (along with test data protection) provide an incentive to fund the expensive human clinical trials necessary to verify and validate the clinical benefits.”

https://www.liebertpub.com/doi/full/10.1089/blr.2018.29073.cmh